23 February 2023 in Proceedings of the National Academy of Sciences
Defining the ontogeny of tumor-associated macrophages (TAM) is important to develop therapeutic targets for mesothelioma. We identified two distinct macrophage populations in mouse peritoneal and pleural cavities, the monocyte-derived, small peritoneal/pleural macrophages (SPM), and the tissue-resident large peritoneal/pleural macrophages (LPM). SPM rapidly increased in tumor microenvironment after tumor challenge and contributed to the vast majority of M2-like TAM. The selective depletion of M2-like TAM by conditional deletion of the Dicer1 gene in myeloid cells (D −/− ) promoted tumor rejection. Sorted SPM M2-like TAM initiated tumorigenesis in vivo and in vitro, confirming their capacity to support tumor development. The transcriptomic and single-cell RNA sequencing analysis demonstrated that both SPM and LPM contributed to the tumor microenvironment by promoting the IL-2-STAT5 signaling pathway, inflammation, and epithelial–mesenchymal transition. However, while SPM preferentially activated the KRAS and TNF-α/NFkB signaling pathways, LPM activated the IFN-γ response. The importance of LPM in the immune response was confirmed by depleting LPM with intrapleural clodronate liposomes, which abrogated the antitumoral memory immunity. SPM gene signature could be identified in pleural effusion and tumor from patients with untreated mesothelioma. Five genes, TREM2, STAB1, LAIR1, GPNMB , and MARCO , could potentially be specific therapeutic targets. Accordingly, Trem2 gene deletion led to reduced SPM M2-like TAM with compensatory increase in LPM and slower tumor growth. Overall, these experiments demonstrate that SPM M2-like TAM play a key role in mesothelioma development, while LPM more specifically contribute to the immune response. Therefore, selective targeting of monocyte-derived TAM may enhance antitumor immunity through compensatory expansion of tissue-resident TAM.
2 February 2022 in American Journal of Transplantation
Over 2.5% of deaths in Canada occur as a result from Medical Assisting in Dying (MAID), and a subset of these deaths result in organ donation. However, detailed outcomes of lung transplant recipients using these donors is lacking. This is a retrospective single center cohort study comparing lung transplantation outcomes after donation using MAID donors compared to neurologically determined death and controlled donation after circulatory death (NDD/cDCD) donors from February 2018 to July 2021. Thirty-three patients received lungs from MAID donors, and 560 patients received lungs from NDD/cDCD donors. The donor diagnoses leading to MAID provision were: degenerative neurological diseases (n=33), and end stage organ failure (n=5). MAID donors were significantly older than NDD/cDCD donors [56 (IQR 49-64) years vs. 48 (32-59); P = .0009]. Median ventilation period and 30 days mortality were not significantly different between MAID and NDD/cDCD lungs recipients (ventilation: 1 day (1-3) vs 2 days (1-3); p=.37, deaths 0% (0/33) vs. 2% (11/560), p=.99 respectively). Intermediate-term outcomes were also similar. In summary, lung transplantation using donors after MAID, recipient outcomes are excellent. Therefore, where this practice is permitted, donation after MAID should be strongly considered for lung transplantation as a way to respect donor wishes while substantially improving outcomes for recipients with end-stage lung disease.
3 May 2024 in European Journal of Surgical Oncology
14 October 2022 in Surgical Case Reports
Background: Extrapulmonary tuberculosis commonly affects the lymphatic system, nervous system, and gastrointestinal system. Tuberculous infection in the muscle is very rare. Moreover, tuberculous infection in the diaphragm is extremely rare. We herein report a case of tuberculomas in the diaphragm and posterior mediastinum that were successfully diagnosed and treated. Case presentation: We encountered a 62-year-old woman with a tuberculoma in the diaphragm. The patient presented with mild dyspnea. Computed tomography showed a mass in the left diaphragm, focal thickening of the posterior mediastinum, and multiple nodules in the lungs. Positron emission tomography–computed tomography showed increased uptake in the left diaphragm mass and thickening of the posterior mediastinum; therefore, we considered the masses to be malignant and planned surgical resection. However, the patient was diagnosed with tuberculosis from a sputum culture, and she was treated with anti-tuberculous therapy. The masses in the diaphragm and posterior mediastinum had become enlarged after 6 months of anti-tuberculous therapy; therefore, the patient underwent resection of both masses. Tuberculous infection was histologically confirmed in each lesion. She was pathologically diagnosed with tuberculous abscesses in the diaphragm and posterior mediastinum and began treatment with anti-tuberculosis drugs. Conclusions: Preoperative diagnosis of a tuberculoma in the diaphragm is usually difficult, and surgical intervention is important for both diagnosis and treatment.
1 January 2026 in Surgical Case Reports
INTRODUCTION: Dedifferentiated liposarcomas of the mediastinum are exceedingly rare, and surgical resection is the primary treatment of choice. Mediastinal mass syndrome (MMS) is an oncological emergency characterized by compression or invasion of the heart, great vessels, or trachea by a large mediastinal tumor, particularly during the induction of anesthesia. We report a case of a giant dedifferentiated liposarcoma in the anterior mediastinum, surgically resected due to severe cardiac compression and presenting as an oncological emergency.CASE PRESENTATION: A 70-year-old male presented with palpitations, generalized fatigue, and chest tightness. Chest radiography revealed an enlarged mediastinal shadow, prompting referral to our hospital. CT revealed a rapidly growing, giant anterior mediastinal tumor measuring 22 × 14.5 × 8.5 cm. The mass caused significant cardiac compression and extended into the pleural cavity. A CT-guided percutaneous biopsy confirmed a dedifferentiated liposarcoma. Given the patient’s presentation of tachycardia and relatively low blood pressure secondary to the large tumor, a semi-urgent surgical resection was planned. Surgical resection was performed with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) on standby, anticipating potential hemodynamic decompensation during the induction of general anesthesia and surgery. Remarkably, the patient’s hemodynamics remained stable throughout the induction of general anesthesia, without requiring VA-ECMO support. A clamshell incision allowed for complete tumor resection, including a portion of the pericardium. Postoperatively, the patient recovered uneventfully, except for transient paroxysmal atrial fibrillation and heart failure. The final pathological diagnosis confirmed dedifferentiated liposarcoma, with tumor cells affecting the pericardial and anterior chest wall surgical margins. The patient received postoperative radiation therapy and adjuvant chemotherapy and has remained free of recurrence for 1 year after surgery.CONCLUSIONS: We successfully performed semi-urgent surgery in a patient with a rapidly growing, giant anterior mediastinal mass causing severe cardiac compression, with VA-ECMO on standby. As MMS constitutes an oncologic emergency, careful assessment of subjective symptoms and imaging findings is required to determine the need for preparing or initiating extracorporeal life support.